
Ravi Sharad Lakdawala, M.D.
Education and Training
2008 | B.A., Medical Sciences – Cum Laude Minor in Economics Boston University Boston, MA |
2011 | Doctor of Medicine Boston University School of Medicine Boston, MA |
2011-2012 | Internship - Internal Medicine Boston University/ Boston Medical Center Boston MA |
2012-2014 | Residency – Internal Medicine Boston University/ Boston Medical Center Boston, MA |
2014-2016 | Fellowship - Nephrology LAC+USC Medical Center Los Angeles, CA |
Licensure and Certification
- Medical Board of California Licensure: 2014
- American Board of Internal Medicine Certification: 2014
Memberships in Professional Societies
- American Society of Nephrology
- National Kidney Foundation
Honors
Ariel Weisman Teaching Award
Outstanding Achievement in Clinical Teaching
Boston University Medical Campus
Clinical Study Location
Tower Nephrology Medical Group, 8635 West 3rd Street Suite 485W Los Angeles, CA 90048
DaVita of Beverly Hills, 50 N. La Cienega Blvd. #300 Beverly Hills, CA 90211
DaVita of Crescent Heights, 8151 Beverly Blvd Los Angeles, CA 90048
Clinical Studies
Sub-Investigator | *2016 | ICH Good Clinical Practice for Clinical Trail Sites (Certificates) |
Sub-Investigator | 2016 | A Phase 3 Randomized, Open-Label (Sponsor-Blind), Active-Controlled, Parallel-Group, Multi-Center, Event Driven Study in Dialysis Subjects with Anemia Associated with Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch from Erythopoietin- Stimulating Agents. |
Sub-Investigator | 2016 | A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, active Control Study to Demonstrate the Safey and Effectiveness of Neutrolin in Preventing Catheter-Related Bloodstream infections in Subjects receiving Hemodialysis Therapy as treatment for End Stage Renal Disease |
Sub-Investigator | 2016 | Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects with Non-Dependent Chronic Kidney Disease (NDD-CKD) (Pro2tect – Conversion) |
2014 | Quality Improvement Research Developed, studied, and executed a process to improve the transition from the inpatient setting to the affiliated outpatient dialysis unit for dialysis patients at LAC+USC Medical Center. LAC+USC Medical Center, Los Angeles, CA |
|
2012 | Quality Improvement Research Developed, studied, and executed a process to decrease the time to first antibiotic administration for septic patients in the inpatient wards at Boston Medical Center. Presented to the Boston Medical Center Department of Medicine and the Quality Improvement Department. Boston Medical Center, Boston, MA |
Publications
- Lakdawala RS and Abdelmalek JA. “IgA Nephropathy.” Medicine Morning Report: Beyond the Pearls. Ed. Dasgupta R and Koolaee RM. (Pending book publication, September 2015)
- Lakdawala RS and Abdelmalek JA. “Nephrolithiasis.” Medicine Morning Report: Beyond the Pearls. Ed. Dasgupta R and Koolaee RM. (Pending book publication, September 2015)
- Campese VC and Lakdawala RS. “The Challenges of Blood Pressure Control in Dialysis Patients.” Clinical Dialysis. Ed. Nissenson AR and Fine RN. (Pending book punlication, 2015)
Abstracts and Presentations
- Lakdawala RS, Wachterman M. Symptomatic Anemia Due to Gastric Invasion of Hepatocelluar Carcinoma. Oral Presentation at Senior Research Academic Day, Boston University School of Medicine; 2014 June 6; Boston, MA
- Ghaffari A, Lakdawala RS. “Peritoneal Dialysis Solution Shortage: A Short-term Management Strategy.” Presented at Quality Improvement Slide Forum at Annual Dialysis Conference; 2015 Feb 2; New Orleans, CA.
Volunteer Experience
2012-2014 | Peer Mentor Boston University Internal Medicine Residency Program Boston, MA |
2012-2014 | Developer- Internal Medicine Intern Handbook Boston University Internal Medicine Residency Program Boston, MA |
Languages
- English – Fluent written and spoken
- Spanish –Fluent written and spoken
- Gujarati – Conversational